US 8252541
Sodium channel protein type III α-subunit splice variant
granted A61PA61P1/00A61P11/06
Quick answer
US patent 8252541 (Sodium channel protein type III α-subunit splice variant) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P1/00, A61P11/06, A61P25/00, A61P25/18